Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis.
about
Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia.Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues.Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis.Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions.Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts.Targets of therapy in progressive MS.Differential contribution of microglia and monocytes in neurodegenerative diseases.Brain Region-dependent Heterogeneity and Dose-dependent Difference in Transient Microglia Population Increase during Lipopolysaccharide-induced Inflammation.CNS inflammation and neurodegeneration.Inflammation in CNS Neurodegenerative Diseases.The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation.The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets.Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer's DiseaseFibronectin aggregates promote features of a classically and alternatively activated phenotype in macrophages
P2860
Q45829514-18849B89-9A38-48B6-80E9-848D3510C502Q45874115-84EACCFA-4A08-4C38-A01B-3E121248C26FQ47126490-B330BE21-8248-469C-9960-0761F128EF05Q47228726-ED68E14D-1AC7-4814-BCC1-745569F2E498Q47339103-9B3F73FF-EA80-4D9E-87EB-6C1A3CCA4BFEQ47774503-A548760F-D1A0-44F4-9ED0-2A68A775C9A7Q48141250-BD8FD76B-6FE8-4E45-9A33-96F19A5F1326Q49357545-81A341B6-5BFB-47D0-A056-E98D366A4B1CQ50223200-CE7326BA-2A85-4810-B055-C256D3275A1AQ51765219-B5042CBE-FAB4-4950-A412-2F49C785AE6AQ52669235-2E07E0A3-B5CF-498E-9CAD-A5B0672CA007Q55211956-AD81E005-0342-4717-B708-F3BFC9073CBBQ55416173-9CDE5471-5048-4096-A784-5B2D5ED3E0E1Q55428811-D369C342-E249-4CA1-B96C-FD199F5688AAQ57817388-5351693A-B384-4B0D-9BF4-BFCD9C415115Q58803080-7EF37E78-E33B-4A46-9DA3-FCDE59B516CE
P2860
Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Loss of 'homeostatic' microgli ...... in active multiple sclerosis.
@en
Loss of 'homeostatic' microgli ...... in active multiple sclerosis.
@nl
type
label
Loss of 'homeostatic' microgli ...... in active multiple sclerosis.
@en
Loss of 'homeostatic' microgli ...... in active multiple sclerosis.
@nl
prefLabel
Loss of 'homeostatic' microgli ...... in active multiple sclerosis.
@en
Loss of 'homeostatic' microgli ...... in active multiple sclerosis.
@nl
P2860
P50
P356
P1433
P1476
Loss of 'homeostatic' microgli ...... n in active multiple sclerosis
@en
P2093
Oleg Butovsky
Simon Hametner
P2860
P304
P356
10.1093/BRAIN/AWX113
P407
P577
2017-07-01T00:00:00Z